These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2576668)

  • 1. Additional benefits of combining beta-blockade and renal vasodilation in the treatment of mild to moderate hypertension: Tertatolol International Multicentre Study results.
    Agnes E; Prost JF; Laher MS
    J Hypertens Suppl; 1989 Dec; 7(6):S270-1. PubMed ID: 2576668
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tertatolol--characteristics of the drug].
    Tomaszewski R; Kliz J
    Wiad Lek; 1992 Mar; 45(5-6):196, 200, 204 passim. PubMed ID: 1360731
    [No Abstract]   [Full Text] [Related]  

  • 3. European experience with artex: the Tertatolol International Multicentre Study (TIMS).
    Laher MS
    Cardiology; 1993; 83 Suppl 1():25-31. PubMed ID: 7903212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Tertatolol International Multicenter Study (T.I.M.S.). Predicting factors of an efficient therapy.
    Agnes E; Vandermercken C; Prost JF; Safar ME
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):296S-302S. PubMed ID: 2573379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular response to adrenergic stimulation during treatment with tertatolol. A new non-cardioselective beta-blocking agent in primary hypertensive patients.
    Fasano ML; Gaeta I; De Simone G; Iannuzzi R; Ferrara LA
    Jpn Heart J; 1991 Jul; 32(4):435-44. PubMed ID: 1683411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of salt intake on the antihypertensive effect of carvedilol.
    Ruilope LM; Lahera V
    J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the antihypertensive and renal effects of tertatolol and nadolol in hypertensive patients with mild renal impairment.
    Fallo F; Gregianin M; Bui F; Macrì C; Folino P; Mantero F
    Eur J Clin Pharmacol; 1991; 40(3):309-11. PubMed ID: 1676368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-Blockers in the Treatment of Hypertension in the 90's: Experience with Tertatolol. Conference proceedings. Istanbul, Turkey, October 19, 1993.
    Cardiology; 1993; 83 Suppl 1():1-72. PubMed ID: 7903209
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy and tolerability of tertatolol in the treatment of mild to moderate arterial hypertension. Results of a French multicenter study with 2,338 patients treated over one year].
    Herpin D; Piron J; Bajou B; Lecasble M
    Ann Cardiol Angeiol (Paris); 1989 Oct; 38(8):503-7. PubMed ID: 2574560
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of a vasodilating beta-blocker and a cardioselective beta-blocker in long-term treatment of hypertension: a European multicentre study.
    Ambrosioni E; Birkenhäger W; De Leeuw PW; Dal Palù C; Demanet JC; Groothold G; Libretti A; Mailland F; Malacco E; Poli A
    J Hypertens Suppl; 1989 Dec; 7(6):S266-7. PubMed ID: 2576667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative renal and cardiac effects of tertatolol and enalapril in essential hypertension.
    Ribstein J; Du Cailar G; Brouard R; Mimran A
    Cardiology; 1993; 83 Suppl 1():57-63. PubMed ID: 7903217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of novel renal properties of tertatolol.
    Guillet C
    Cardiology; 1993; 83 Suppl 1():64-9. PubMed ID: 7903218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in beta blockade. Therapeutic implications in hypertension. Proceedings of the First International Symposium on Tertatolol, 15th June, 1985, Milano, Italy.
    Am J Nephrol; 1986; 6 Suppl 2():1-116. PubMed ID: 2879463
    [No Abstract]   [Full Text] [Related]  

  • 14. The kidney and strategies for the treatment of hypertension.
    Hollenberg NK
    Am J Med; 1984 Oct; 77(4A):60-3. PubMed ID: 6207726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of clinical safety and efficacy of tertatolol.
    Vivet P
    Cardiology; 1993; 83 Suppl 1():41-50. PubMed ID: 7903214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined antihypertensive therapy: review of multicenter studies conducted in foreign countries].
    Shabalin AV; Nikitin IuP
    Ter Arkh; 1999; 71(8):74-8. PubMed ID: 10515043
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of tertatolol on lipid profile.
    Diehm C; Jacobsen O; Amendt K
    Cardiology; 1993; 83 Suppl 1():32-40. PubMed ID: 7903213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celiprolol and verapamil in the treatment of essential hypertension.
    McInnes GT; McLenachan JM; Henderson E; Herrick AL; Dargie HJ
    Am Heart J; 1988 Nov; 116(5 Pt 2):1437-8. PubMed ID: 2903656
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypertension and the kidney: implications of the kidney for effective antihypertensive therapy.
    Hollenberg NK
    Medicographia; 1987; 9(3):2-4. PubMed ID: 11539067
    [No Abstract]   [Full Text] [Related]  

  • 20. Antihypertensive efficacy of a new long acting hydralazine like vasodilator, ISF 2469 in combination with a betablocker and a diuretic.
    van Brummelen P; Bühler FR; Kiowski W; Bolli P; Bertel O
    Int J Clin Pharmacol Biopharm; 1979 Oct; 17(10):380-5. PubMed ID: 40887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.